Live
- Zaggle strengthens Leadership with the appointment of ex-Kotak Mahindra Bank’s Virat Diwanji as Additional Director
- Don't read too much into meeting with our Party leaders: DK Suresh
- AG&P Pratham Devoted to Transforming Tada into a Green Town by expanding its CNG infrastructure catering to SRI CITY
- Hyderabad CSMP to be included in AMRUT 2.0 - Chief Minister Revanth Reddy's appeal to Union Minister Khattar for support on Metro Rail Phase 2
- Ujjivan celebrates the rich cultural heritage of Telangana with a colorful floral tribute to Bathukamma
- DGCA issues safety guidance for Boeing 737 aircraft for low-visibility landings
- Rahul Gandhi Explores Dalit Cuisine In Maharashtra, Engages In Dialogue On Caste Discrimination
- Supreme Court Stays Death Penalty Of Sukhjinder Singh In 2010 Child Murder Case
- Conspiracy against Nitish govt during floor test, says Bihar Police
- Hero Motors withdraws draft IPO papers for Rs 900 crore issue
Pricing pressure hits pharma exports
Pharma exports from India registered a negative growth of four per cent during the first five months of the current fiscal owing to increased regulatory issues coupled with pricing pressure in global markets, according to Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Hyderabad: Pharma exports from India registered a negative growth of four per cent during the first five months of the current fiscal owing to increased regulatory issues coupled with pricing pressure in global markets, according to Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Udaya Bhaskar, Director General, Pharmexcil, said: “The pharma exports to other countries witnessed a decline of 7.9 per cent during the April-July period, while recovered to four per cent in August leaving the over-all growth at minus four per cent till August this year. Till July, pharma exports registered minus 7.9 per cent growth. Subsequently it recovered in August and stood at minus four per cent.
There was four per cent growth in August. Pricing pressure is one of the factors (for decline in exports). To some extent import alerts (by US FDA on Indian plants), regulatory issues and currency fluctuation, are some of the factors contributed to downward growth.” He, however, hoped that the overall exports will recover and come into positive zone for the full year as exports are expected to take an uptick from September.
